Similarly, in another retrospective study of HL female patients receiving frontline CT (n = 54), mainly ABVD or salvage CT, including high cumulative doses of alkylating agents (n = 7), no significant reduction in POF could be documented despite the use of GnRH-a. This evidence concerns the gene GNRH1 and Hodgkins lymphoma.